HIV-1 Reverse Transcriptase (RT) Polymorphism 172K Suppresses the Effect of Clinically Relevant Drug Resistance Mutations to Both Nucleoside and Non-nucleoside RT Inhibitors.
Hachiya, A., Marchand, B., Kirby, K.A., Michailidis, E., Tu, X., Palczewski, K., Ong, Y.T., Li, Z., Griffin, D.T., Schuckmann, M.M., Tanuma, J., Oka, S., Singh, K., Kodama, E.N., Sarafianos, S.G.(2012) J Biol Chem 287: 29988-29999
- PubMed: 22761416 
- DOI: 10.1074/jbc.M112.351551
- Primary Citation of Related Structures:  
4DG1 - PubMed Abstract: 
Polymorphisms have poorly understood effects on drug susceptibility and may affect the outcome of HIV treatment. We have discovered that an HIV-1 reverse transcriptase (RT) polymorphism (RT(172K)) is present in clinical samples and in widely used laborat ...